Home/Filings/4/0001209191-13-018202
4//SEC Filing

Otvos James D. 4

Accession 0001209191-13-018202

CIK 0001168197other

Filed

Mar 24, 8:00 PM ET

Accepted

Mar 25, 4:28 PM ET

Size

8.0 KB

Accession

0001209191-13-018202

Insider Transaction Report

Form 4
Period: 2013-03-01
Otvos James D.
EVP, Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2013-03-01$9.65/sh+3,151$30,407476,041 total
  • Award

    Stock Option (right to buy)

    2013-03-01+18,90518,905 total
    Exercise: $9.65Exp: 2023-02-28Common Stock (18,905 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    180,167
Footnotes (2)
  • [F1]Represents shares issuable upon the vesting of restricted stock units granted to the reporting person on March 1, 2013. The restricted stock units vest 100% on March 1, 2016, subject to the reporting person's continuous service with the issuer as of the vesting date.
  • [F2]The option vests over a period of four years, with 1/16 of the shares underlying the option vesting on a quarterly basis, starting June 1, 2013, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.

Issuer

LIPOSCIENCE INC

CIK 0001168197

Entity typeother

Related Parties

1
  • filerCIK 0001530878

Filing Metadata

Form type
4
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 4:28 PM ET
Size
8.0 KB